Figure 2.(a)Results of the Monte-Carlo simulations describing a population of elderly patients after a single oral dose of propranolol.-The Brain and Propranolol Pharmacokinetics in the Elderly

<p>In effort to identify the recommended Propranolol dosage for elderly patients, we identified<br> the patient package inserts from the Food and Drug Administration (FDA) Inderal label, who<br> manufacture propranolol. Based from FDA Wyeth Propranolol label, for dosing in the geriatric<br> population,the label states that there were not sufficient numbers of clinical study participants who<br> were 65-years and older to properly determine the difference in response young and elderly<br> patients.</p>